VISTO MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VISTO MED
Largest movements
- Intangible fixed assets -€15,000
down €15,000 (-28.6%), from €52,500 to €37,500
- Cash -€7,179
down €7,179 (-4.7%), from €153,121 to €145,942
mainly Contributions, distributions and other (-€155,930) and Deferred charges and accrued income (-€3,408)
- Deferred charges and accrued income +€3,408
up €3,408 (+51.9%), from €6,572 to €9,981
- Reserves -€123,924
down €123,924 (-58.3%), from €212,483 to €88,560
- Other debts +€103,102
up €103,102 (+188%), from €54,787 to €157,889
- Depreciation -€1,755
down €1,755 (-9.4%), from €18,750 to €16,994
- Taxes +€749
up €749 (+6.1%), from €12,221 to €12,970
- Financial income +€734
up €734 (+516%), from €142 to €876
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €287,342 | €265,549 | -€21,794 | -7.6% |
| Fixed assets | 21/28 | €55,554 | €38,560 | -€16,994 | -30.6% |
| Intangible fixed assets | 21 | €52,500 | €37,500 | -€15,000 | -28.6% |
| Tangible fixed assets | 22/27 | €3,024 | €1,030 | -€1,994 | -65.9% |
| Plant, machinery and equipment | 23 | €3,024 | €1,030 | -€1,994 | -65.9% |
| Financial fixed assets | 28 | €30 | €30 | = | 0.0% |
| Current assets | 29/58 | €231,788 | €226,989 | -€4,800 | -2.1% |
| Amounts receivable within one year | 40/41 | €72,095 | €71,066 | -€1,029 | -1.4% |
| Trade receivables | 40 | €1,500 | - | -€1,500 | |
| Other amounts receivable | 41 | €70,595 | €71,066 | +€471 | +0.7% |
| Cash at bank and in hand | 54/58 | €153,121 | €145,942 | -€7,179 | -4.7% |
| Deferred charges and accrued income | 490/1 | €6,572 | €9,981 | +€3,408 | +51.9% |
| Total equity and liabilities | 10/49 | €287,342 | €265,549 | -€21,794 | -7.6% |
| Equity | 10/15 | €231,083 | €107,160 | -€123,924 | -53.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €212,483 | €88,560 | -€123,924 | -58.3% |
| Distributable reserves | 133 | €212,483 | €88,560 | -€123,924 | -58.3% |
| Amounts payable | 17/49 | €56,259 | €158,389 | +€102,130 | +182% |
| Amounts payable within one year | 42/48 | €55,659 | €158,389 | +€102,730 | +185% |
| Trade debts | 44 | €872 | €500 | -€372 | -42.7% |
| Suppliers | 440/4 | €872 | €500 | -€372 | -42.7% |
| Other amounts payable | 47/48 | €54,787 | €157,889 | +€103,102 | +188% |
| Accrued charges and deferred income | 492/3 | €600 | - | -€600 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €18,750 | €16,994 | -€1,755 | -9.4% |
| Other operating charges | 640/8 | €673 | €695 | +€22 | +3.3% |
| Gross operating margin | 9900 | €63,221 | €63,073 | -€148 | -0.2% |
| Operating profit (loss) | 9901 | €43,799 | €45,384 | +€1,585 | +3.6% |
| Financial income | 75/76B | €142 | €876 | +€734 | +516% |
| Recurring financial income | 75 | €142 | €876 | +€734 | +516% |
| Financial charges | 65/66B | €1,543 | €1,282 | -€261 | -16.9% |
| Recurring financial charges | 65 | €1,543 | €1,282 | -€261 | -16.9% |
| Profit (loss) for the period before taxes | 9903 | €42,398 | €44,977 | +€2,579 | +6.1% |
| Income taxes | 67/77 | €12,221 | €12,970 | +€749 | +6.1% |
| Profit (loss) for the period | 9904 | €30,177 | €32,007 | +€1,830 | +6.1% |
| Profit (loss) for the period to be appropriated | 9905 | €30,177 | €32,007 | +€1,830 | +6.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.